Fleet Therapeutics
Boston, US · Founded 2019 · Delaware corporation
Founders & leadership
DP
Deborah PalestrantExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$24.1MraisedOct 2021 · 4 investors · OtherRule 506(b)
Officers, directors & promoters on the filing
- Deborah PalestrantExecutive Officer, Director
- Offering amount
- $58.1M
- Amount sold
- $24.1M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.